A novel albumin nanocomplex containing both small interfering RNA and gold nanorods for synergetic anticancer therapy
Authors:
- 30 April 2015
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 7 (20) , 9229-9237
Abstract
Therapeutic nanocomplexes have been extensively developed for the effective treatment of aggressive cancers because of their outstanding versatility, easy manipulation, and low cytotoxicity. In this study, we describe the synthesis of a novel bovine serum albumin (BSA)-based nanocomplex harboring both Bcl-2-specific small interfering RNA (siRNA) and gold (Au) nanorods (siRNA and rods encapsulated in BSA; SREB) with the aim of developing a targeted breast cancer therapeutic. The SREB complexes contained 2 × 105 siRNA molecules and eight Au nanorods per BSA complex and were successively functionalized with polyethylene glycol (PEG) and anti-ErbB-2 antibodies to facilitate active targeting. The synergetic therapeutic activity originating from the two components effectively induced cell death (∼80% reduction in viability compared with control cells) in target breast cancer cells after a single dose of laser irradiation. Intracellular SREB nanocomplex decomposition by proteolytic enzymes resulted in simultaneous RNA interference and thermal ablation, thus leading to apoptosis in the targeted cancer cells. Moreover, these therapeutic effects were sustained for approximately 72 hours. The intrinsic biocompatibility, multifunctionality, and potent in vitro anticancer properties of these SREB nanocomplexes indicate that they have great therapeutic potential for in vivo targeted cancer therapy, in addition to other areas of nanomedicine.Keywords
This publication has 39 references indexed in Scilit:
- PEGylated PAMAM dendrimer–doxorubicin conjugate-hybridized gold nanorod for combined photothermal-chemotherapyBiomaterials, 2014
- Co-delivery of siRNAs and anti-cancer drugs using layered double hydroxide nanoparticlesBiomaterials, 2014
- Chemical modification of inorganic nanostructures for targeted and controlled drug delivery in cancer treatmentJournal of Materials Chemistry B, 2013
- On‐Demand Drug Release System for In Vivo Cancer Treatment through Self‐Assembled Magnetic NanoparticlesAngewandte Chemie, 2013
- Gold Nanorods as Contrast Agents for Biological Imaging: Optical Properties, Surface Conjugation and Photothermal Effects†Photochemistry and Photobiology, 2009
- PNIPAM Gel-Coated Gold Nanorods for Targeted Delivery Responding to a Near-Infrared LaserBioconjugate Chemistry, 2009
- Nanoparticle therapeutics: an emerging treatment modality for cancerNature Reviews Drug Discovery, 2008
- Nanoparticles in Medicine: Therapeutic Applications and DevelopmentsClinical Pharmacology & Therapeutics, 2007
- Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold NanorodsJournal of the American Chemical Society, 2006
- Characterization of hemoglobin, water, and NIR scattering in breast tissue: analysis of intersubject variability and menstrual cycle changesJournal of Biomedical Optics, 2004